Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

A comparison between follitropin alpha filled by mass and follitropin alpha filled by bioassay in the same egg donors.

Martinez G, Sanguineti F, Sepulveda J, Dorey J, Arici A, Patrizio P.

Reprod Biomed Online. 2007 Jan;14(1):26-8.

PMID:
17207327
2.

A comparison between follitropin α filled by mass and follitropin a filled by bioassay in the same egg donors.

Martinez G, Sanguineti F, Sepulveda J, Dorey J, Arici A, Patrizio P.

Reprod Biomed Online. 2011 Feb;22 Suppl 1:S20-2. doi: 10.1016/S1472-6483(11)60005-9.

PMID:
21575845
3.

Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass.

Balasch J, Fábregues F, Peñarrubia J, Creus M, Manau D, Vidal E, Casamitjana R, Vanrell JA.

Reprod Biomed Online. 2004 Apr;8(4):408-13.

PMID:
15149563
4.
5.
6.
7.

Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?

Orvieto R, Nahum R, Rabinson J, Ashkenazi J, Anteby EY, Meltcer S.

Fertil Steril. 2009 Apr;91(4 Suppl):1522-5. doi: 10.1016/j.fertnstert.2008.08.112. Epub 2008 Oct 11.

PMID:
18851846
8.

Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).

Lenton E, Soltan A, Hewitt J, Thomson A, Davies W, Ashraf N, Sharma V, Jenner L, Ledger W, McVeigh E.

Hum Reprod. 2000 May;15(5):1021-7.

PMID:
10783345
9.

Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies.

Saz-Parkinson Z, López-Cuadrado T, Bouza C, Amate JM.

BioDrugs. 2009;23(1):37-42. doi: 10.2165/00063030-200923010-00004. Review.

PMID:
19344190
11.

An observational study of assisted reproductive technology outcomes in new European Union member states: an overview of protocols used for ovarian stimulation.

Vlaisavljević V, Meden-Vrtovec H, Lewandowski P, Radwan M, Langerova A, Vicena M, Války J, Herman M, Usoniene A, Treijs G.

Curr Med Res Opin. 2010 Apr;26(4):819-25. doi: 10.1185/03007990903577118.

PMID:
20121657
12.

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.

Fauser BC, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BM; Engage Investigators.

Reprod Biomed Online. 2010 Nov;21(5):593-601. doi: 10.1016/j.rbmo.2010.06.032. Epub 2010 Jun 30.

PMID:
20843746
13.

Follicle-stimulating hormone in clinical practice: an update.

Daya S.

Treat Endocrinol. 2004;3(3):161-71. Review.

PMID:
16026112
14.

Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.

Messinis IE, Milingos S, Zikopoulos K, Hasiotis G, Seferiadis K, Lolis D.

Hum Reprod. 1998 Sep;13(9):2415-20.

PMID:
9806260
15.

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.

De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N, Mollo A; Italian Collaborative Group on Recombinant Human Luteinizing Hormone.

Hum Reprod. 2005 Feb;20(2):390-6. Epub 2004 Dec 2.

PMID:
15576390
16.

Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study.

Blockeel C, De Vos M, Verpoest W, Stoop D, Haentjens P, Devroey P.

Hum Reprod. 2009 Nov;24(11):2910-6. doi: 10.1093/humrep/dep253. Epub 2009 Jul 17.

PMID:
19617207
20.

Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone.

De Placido G, Alviggi C, Mollo A, Strina I, Varricchio MT, Molis M.

Hum Reprod. 2000 Jan;15(1):17-20.

PMID:
10611181

Supplemental Content

Support Center